185 related articles for article (PubMed ID: 24890041)
1. Combination of 9-aminoacridine with Campath-1H provides effective therapy for a murine model of adult T-cell leukemia.
Ju W; Zhang M; Petrus M; Maeda M; Pise-Masison CA; Waldmann TA
Retrovirology; 2014 Jun; 11():43. PubMed ID: 24890041
[TBL] [Abstract][Full Text] [Related]
2. Markedly additive antitumor activity with the combination of a selective survivin suppressant YM155 and alemtuzumab in adult T-cell leukemia.
Chen J; Pise-Masison CA; Shih JH; Morris JC; Janik JE; Conlon KC; Keating A; Waldmann TA
Blood; 2013 Mar; 121(11):2029-37. PubMed ID: 23321252
[TBL] [Abstract][Full Text] [Related]
3. Small-molecule inhibitor which reactivates p53 in human T-cell leukemia virus type 1-transformed cells.
Jung KJ; Dasgupta A; Huang K; Jeong SJ; Pise-Masison C; Gurova KV; Brady JN
J Virol; 2008 Sep; 82(17):8537-47. PubMed ID: 18550670
[TBL] [Abstract][Full Text] [Related]
4. Effective treatment of a murine model of adult T-cell leukemia using depsipeptide and its combination with unmodified daclizumab directed toward CD25.
Chen J; Zhang M; Ju W; Waldmann TA
Blood; 2009 Feb; 113(6):1287-93. PubMed ID: 18948574
[TBL] [Abstract][Full Text] [Related]
5. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
[TBL] [Abstract][Full Text] [Related]
6. Effective therapy for a murine model of adult T-cell leukemia with the humanized anti-CD52 monoclonal antibody, Campath-1H.
Zhang Z; Zhang M; Goldman CK; Ravetch JV; Waldmann TA
Cancer Res; 2003 Oct; 63(19):6453-7. PubMed ID: 14559836
[TBL] [Abstract][Full Text] [Related]
7. Augmented efficacy with the combination of blockade of the Notch-1 pathway, bortezomib and romidepsin in a murine MT-1 adult T-cell leukemia model.
Yu P; Petrus MN; Ju W; Zhang M; Conlon KC; Nakagawa M; Maeda M; Bamford RN; Waldmann TA
Leukemia; 2015 Mar; 29(3):556-66. PubMed ID: 25118879
[TBL] [Abstract][Full Text] [Related]
8. Dual targeting of transformed and untransformed HTLV-1-infected T cells by DHMEQ, a potent and selective inhibitor of NF-kappaB, as a strategy for chemoprevention and therapy of adult T-cell leukemia.
Watanabe M; Ohsugi T; Shoda M; Ishida T; Aizawa S; Maruyama-Nagai M; Utsunomiya A; Koga S; Yamada Y; Kamihira S; Okayama A; Kikuchi H; Uozumi K; Yamaguchi K; Higashihara M; Umezawa K; Watanabe T; Horie R
Blood; 2005 Oct; 106(7):2462-71. PubMed ID: 15956280
[TBL] [Abstract][Full Text] [Related]
9. Selective targeting of JAK/STAT signaling is potentiated by Bcl-xL blockade in IL-2-dependent adult T-cell leukemia.
Zhang M; Mathews Griner LA; Ju W; Duveau DY; Guha R; Petrus MN; Wen B; Maeda M; Shinn P; Ferrer M; Conlon KD; Bamford RN; O'Shea JJ; Thomas CJ; Waldmann TA
Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12480-5. PubMed ID: 26396258
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of novel histone deacetylase inhibitor, AR42, in a mouse model of, human T-lymphotropic virus type 1 adult T cell lymphoma.
Zimmerman B; Sargeant A; Landes K; Fernandez SA; Chen CS; Lairmore MD
Leuk Res; 2011 Nov; 35(11):1491-7. PubMed ID: 21802726
[TBL] [Abstract][Full Text] [Related]
11. 9-Aminoacridine inhibition of HIV-1 Tat dependent transcription.
Guendel I; Carpio L; Easley R; Van Duyne R; Coley W; Agbottah E; Dowd C; Kashanchi F; Kehn-Hall K
Virol J; 2009 Jul; 6():114. PubMed ID: 19630958
[TBL] [Abstract][Full Text] [Related]
12. Butein inhibits NF-κB, AP-1 and Akt activation in adult T-cell leukemia/lymphoma.
Ishikawa C; Senba M; Mori N
Int J Oncol; 2017 Aug; 51(2):633-643. PubMed ID: 28586006
[TBL] [Abstract][Full Text] [Related]
13. 9-Aminoacridine-based anticancer drugs target the PI3K/AKT/mTOR, NF-kappaB and p53 pathways.
Guo C; Gasparian AV; Zhuang Z; Bosykh DA; Komar AA; Gudkov AV; Gurova KV
Oncogene; 2009 Feb; 28(8):1151-61. PubMed ID: 19137016
[TBL] [Abstract][Full Text] [Related]
14. Preclinical efficacy of the synthetic retinoid ST1926 for treating adult T-cell leukemia/lymphoma.
El Hajj H; Khalil B; Ghandour B; Nasr R; Shahine S; Ghantous A; Abdel-Samad R; Sinjab A; Hasegawa H; Jabbour M; Hall WW; Zaatari G; Dbaibo G; Pisano C; Bazarbachi A; Darwiche N
Blood; 2014 Sep; 124(13):2072-80. PubMed ID: 25035162
[TBL] [Abstract][Full Text] [Related]
15. Combination therapy for adult T-cell leukemia-xenografted mice: flavopiridol and anti-CD25 monoclonal antibody.
Zhang M; Zhang Z; Goldman CK; Janik J; Waldmann TA
Blood; 2005 Feb; 105(3):1231-6. PubMed ID: 15383455
[TBL] [Abstract][Full Text] [Related]
16. Effective therapy for a murine model of adult T-cell leukemia with the humanized anti-CD2 monoclonal antibody, MEDI-507.
Zhang Z; Zhang M; Ravetch JV; Goldman C; Waldmann TA
Blood; 2003 Jul; 102(1):284-8. PubMed ID: 12649132
[TBL] [Abstract][Full Text] [Related]
17. Thymoquinone synergizes with arsenic and interferon alpha to target human T-cell leukemia/lymphoma.
Houssein M; Fatfat M; Habli Z; Ghazal N; Moodad S; Khalife H; Khalil M; Gali-Muhtasib H
Life Sci; 2020 Jun; 251():117639. PubMed ID: 32272181
[TBL] [Abstract][Full Text] [Related]
18. Curcumin (diferuloylmethane) inhibits constitutive active NF-kappaB, leading to suppression of cell growth of human T-cell leukemia virus type I-infected T-cell lines and primary adult T-cell leukemia cells.
Tomita M; Kawakami H; Uchihara JN; Okudaira T; Masuda M; Takasu N; Matsuda T; Ohta T; Tanaka Y; Ohshiro K; Mori N
Int J Cancer; 2006 Feb; 118(3):765-72. PubMed ID: 16106398
[TBL] [Abstract][Full Text] [Related]
19. p53 dysfunction precedes the activation of nuclear factor-κB during disease progression in mice expressing Tax, a human T-cell leukemia virus type 1 oncoprotein.
Ohsugi T; Ishida T; Shimasaki T; Okada S; Umezawa K
Carcinogenesis; 2013 Sep; 34(9):2129-36. PubMed ID: 23633516
[TBL] [Abstract][Full Text] [Related]
20. Constitutive activation of NF-kappaB in primary adult T-cell leukemia cells.
Mori N; Fujii M; Ikeda S; Yamada Y; Tomonaga M; Ballard DW; Yamamoto N
Blood; 1999 Apr; 93(7):2360-8. PubMed ID: 10090947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]